comparemela.com

Latest Breaking News On - Ladenburg thalmann healthcare conference - Page 2 : comparemela.com

Allarity Therapeutics to Present at Ladenburg Thalmann Healthcare Conference

Allarity Therapeutics to Present at Ladenburg Thalmann Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Beyond Air® To Participate in Three Upcoming Investor Conferences

Beyond Air® To Participate in Three Upcoming Investor Conferences
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Nanox to Present at Two Upcoming Investor Conferences in September 2022

Cognition Therapeutics Announces Participation in September Investment Conferences

06.09.2022 - PURCHASE, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) - Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule .

Lipocine Inc (LPCN) stock surged in the after-hours on Wednesday after a recent announcement

Settlement With Clarus Therapeutics On July 14, 2021, Lipocine Inc entered into a global settlement and license agreement with Clarus Therapeutics Inc (Clarus) to resolve all outstanding claims in the ongoing intellectual property battle between the two companies as well as the ongoing interference proceeding between the two companies. Both companies agreed to dismiss the Lipocine Inc. v Clarus Therapeutics, Inc., No 19-cv-622 (WCB) litigation presently pending in the U.S. District Court for the District of Delaware and interference proceedings captioned Clarus Therapeutics, Inc. v. Lipocine Inc., Interference No. 106,128 presently pending in the U.S. Patent and Trademark. The terms of the settlement remain confidential.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.